New Delhi: Pfizer vaccine is likely to be approved in the country by August. India is reportedly moving to take steps to protect foreign Covid vaccine manufacturers, including Pfizer, from legal liability.
The price in India is said to be around Rs 730 per dose. The health status of first-time recipients of the foreign-made vaccine will be monitored. According to government sources, the vaccine will be made available to the public after its effectiveness is ensured.